市場調査レポート

商品コード

1619028

エレクトロシューティカルの世界市場規模、シェア、成長分析：製品別、タイプ別、用途別、地域別 - 産業予測（2024年～2031年）

Electroceuticals Market Size, Share, Growth Analysis, By Product, By Type, By Application, By Region - Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 767,811円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 898,194円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,028,577円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.87円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のエレクトロシューティカルの市場規模は、2022年に239億米ドルと評価され、2023年の255億7,000万米ドルから2031年には439億4,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは7.0％で成長する見通しです。

エレクトロシューティカル市場は、医療技術の進歩、研究開発費の増加、人口の高齢化、慢性疾患の有病率の上昇などを背景に、大きな成長が見込まれています。非侵襲性デバイスは、患者がより侵襲性の低い治療に傾倒していることから、植え込み型オプションと比較して高い需要が見込まれています。しかし、厳しい規制の枠組み、頻繁な製品回収、長い承認プロセス、高コストといった課題が市場の可能性を妨げる可能性があります。心血管疾患の世界の増加は、特にこれらの疾患に対するエレクトロシューティカルの利用において、市場の拡大をさらに促進する見通しです。各国政府は、研究開発努力を強化するための資金提供を開始しており、今後4年間の市場機会を大幅に拡大する可能性のある支援的な環境を示しています。

市場概要
心臓ペースメーカーおよび植え込み型除細動器
人工内耳
神経調節
- 脊髄刺激装置
- 脳深部刺激装置
- 迷走神経刺激装置
- 仙骨神経刺激装置
- 胃電気刺激装置
- 経皮的電気神経刺激装置
- 経頭蓋磁気刺激装置
- 呼吸電気刺激装置
- 三叉神経刺激装置
- 応答性神経刺激装置
網膜インプラント

エレクトロシューティカル市場規模：タイプ別、CAGR（2024年～2031年）

市場概要
植え込み型エレクトロシューティカル装置
非侵襲性エレクトロシューティカル装置

エレクトロシューティカル市場規模：用途別、CAGR（2024年～2031年）

市場概要
心臓ペースメーカーと植え込み型除細動器（ICD）
- 不整脈
- 心不全
- その他の心臓ペースメーカーおよびICD用途
脊髄刺激装置
- 慢性疼痛
- 背部手術失敗症候群
- 虚血
- パーキンソン病
- 震え
- うつ
- その他のDBS用途
- 尿失禁
- 便失禁
- てんかん
- その他のVNS用途
- 胃不全麻痺
- 肥満
- 治療抵抗性うつ病
- その他のTENS用途
- 片頭痛
- 脊髄損傷
- 注意欠陥・多動性障害

エレクトロシューティカル市場規模、CAGR（2024年～2031年）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比の比較（2021年～2023年）

主要企業プロファイル

Medtronic
Boston scientific corporation
Abbott
Livanova plc
Cochlear ltd.
Microport scientific corporation
Sonova
Nevro corp.
Axonics, Inc.
Neuronetics
Electrocore, Inc.
Neuropace, Inc.
Biotronik
Medico S.R.L.
Zhejiang nurotron biotechnology co., ltd.
Med-EL
Aleva neurotherapeutics
Neurosigma, inc.
Biowave corporation
Soterix medical Inc

結論と推奨事項

Product Code: SQMIG35A2542

Global Electroceuticals Market size was valued at USD 23.9 billion in 2022 and is poised to grow from USD 25.57 billion in 2023 to USD 43.94 billion by 2031, growing at a CAGR of 7.0% during the forecast period (2024-2031).

The electroceuticals market is poised for significant growth, driven by advancements in medical technology, increasing research and development spending, an aging population, and a rising prevalence of chronic diseases. Non-invasive devices are expected to see higher demand compared to implantable options as patients lean towards less invasive treatments. However, challenges such as stringent regulatory frameworks, frequent product recalls, lengthy approval processes, and high costs may hinder market potential. The global rise in cardiovascular diseases will further fuel market expansion, particularly in the utilization of electroceuticals for these conditions. Governments are initiating funding to bolster R&D efforts, indicating a supportive environment that could significantly enhance market opportunities over the next four years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electroceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electroceuticals Market Segmental Analysis

Global Electroceuticals Market is segmented by product, type, application and region. Based on product, the market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, cochlear implants, neuromodulators and retinal implants. Based on type, the market is segmented into implantable electroceutical devices and noninvasive electroceutical devices. Based on application, the market is segmented into cardiac pacemakers & implantable cardioverter defibrillators (ICD) and spinal cord stimulators. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Electroceuticals Market

A key driver of growth in the global electroceuticals market is the increasing incidence of cardiovascular diseases, which are among the leading causes of mortality worldwide. The World Health Organization reports that these diseases result in over 17.3 million deaths annually, with projections suggesting this number may rise to 23.6 million by 2030. Cardiovascular diseases affect approximately 31% of the global population, disproportionately impacting low and middle-income countries, where they account for 80% of fatalities. In the United States alone, over 800,000 deaths attributed to cardiovascular conditions were reported, illustrating a significant opportunity for expansion within the electroceuticals sector. Additionally, innovations and new product launches by key market players further propel market growth in the foreseeable future.

Restraints in the Global Electroceuticals Market

One significant constraint on the Global Electroceuticals market is the limited awareness of electroceutical devices among populations in low and middle-income countries (LMIC). Although high-income nations have successfully adopted a variety of implantable devices, including those for cardiac rhythm management, access remains scarce in LMIC. Research from the American Heart Association indicates that many Latin Americans in the United States are unfamiliar with automated external defibrillators (AEDs) and their operation. This lack of public knowledge is detrimental because it hampers potential survival rates following cardiac arrests, as individuals might not receive essential defibrillation treatment in critical situations.

Market Trends of the Global Electroceuticals Market

The global electroceuticals market is experiencing significant growth, fueled by increased investment from numerous key players such as Medtronic, Boston Scientific, and Abbott Laboratories. This escalating trend is driven by the expanding product portfolios and innovative therapies that address various diseases, alongside strategic initiatives like mergers, acquisitions, and technological advancements. Recent FDA approvals, including Medtronic's Intellis Platform and Boston Scientific's Vercise Genus system, illustrate the rapid development in this sector. As the industry embraces advanced technologies and collaborative efforts, the market is poised for robust expansion, catering to the increasing demand for minimally invasive therapeutic options worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape

Global Electroceuticals Market Size by Product & CAGR (2024-2031)

Market Overview
Cardiac Pacemakers & Implantable Cardioverter Defibrillators
Cochlear Implants
Neuromodulators
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Vagus Nerve Stimulators
- Sacral Nerve Stimulators
- Gastric Electrical Stimulators
- Transcutaneous Electrical Nerve Stimulators
- Transcranial Magnetic Stimulators
- Respiratory Electrical Stimulators
- Trigeminal Nerve Stimulators
- Responsive Neurostimulators
Retinal Implants

Global Electroceuticals Market Size by Type & CAGR (2024-2031)

Market Overview
Implantable Electroceutical Devices
Noninvasive Electroceutical Devices

Global Electroceuticals Market Size by Application & CAGR (2024-2031)

Market Overview
Cardiac Pacemakers & Implantable Cardioverter Defibrillators (ICD)
- Arrhythmia
- Heart Failure
- Other Cardiac Pacemaker & Icd Applications
Spinal Cord Stimulators
- Chronic Pain
- Failed Back Surgery Syndrome
- Ischemia
- Parkinson'S Disease
- Tremors
- Depression
- Other Dbs Applications
- Urine Incontinence
- Fecal Incontinence
- Epilepsy
- Other Vns Applications
- Gastroparesis
- Obesity
- Treatment-Resistant Depression
- Other Tens Applications
- Migraine
- Spinal Cord Injury
- Attention-Deficit/Hyperactivity Disorder

Global Electroceuticals Market Size & CAGR (2024-2031)

North America (Product, Type, Application)
- USA
- Canada
Europe (Product, Type, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston scientific corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Livanova plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microport scientific corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonova
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axonics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Electrocore, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuropace, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medico S.R.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zhejiang nurotron biotechnology co., ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Med-EL
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva neurotherapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neurosigma, inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biowave corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix medical Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments